(MT Newswires) -- Dutch Philips Group (PHG) CEO Roy Jakobs discusses the consequences of the sleep apnea machine recall. The Dutch medical equipment manufacturer has not given a definitive figure for the cost of the recall, as the legal proceedings are not over, but claims that 99% of defective devices have been replaced. While the company has recorded three consecutive quarters of growth, it points to investments in artificial intelligence, estimated at over a billion euros a year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.97 EUR | +1.09% | -3.48% | +22.47% |
May. 24 | Philips: refinancing for 700 million euros | CF |
May. 24 | Royal Philips Prices EUR700 Million of Notes due 2032 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.47% | 25.4B | |
+10.03% | 223B | |
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.05% | 65.01B | |
+15.38% | 53.02B | |
+3.96% | 50.45B | |
+8.37% | 44.15B | |
+3.27% | 36.45B |
- Stock Market
- Equities
- PHIA Stock
- News Philips NV
- Product recalls, renewed growth, investment in AI. Roy Jakobs, Philips CEO